A Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of s.c. Administration of IVF-M HP Inj. Versus Menopur® Inj. in Infertility Women Undergoing Controlled Ovarian Hyperstimulation for Assisted Reproductive Technologies (ART) Such as in Vitro Fertilization-embryo Transfer (IVF-ET)

NCT02458768 Phase 4 COMPLETED Results posted

The objective of this study was to demonstrate the non-inferiority of IVFM HP Inj. by evaluating its efficacy versus Menopur® Inj. in infertility women undergoing the in vitro fertilization and embryo transfer (IVF-ET) among the assisted reproductive technologies.

Details

Lead sponsor	LG Life Sciences
Phase	Phase 4
Status	COMPLETED
Enrolment	112
Start date	2013-07

Conditions

• Infertility, Female

Interventions

• IVF-M HP Inj.
• Menopur® Inj.

Primary outcomes

• Number of Retrieved Oocytes — 36 hrs (±3 hrs) after administration of the ovulation stimulant